B. Braun Avitum Austria
The development of the B. Braun Avitum Group is marked by its rapid expansion in Western and Eastern European Countries. Treatments and sales grew with an average growth of 20% p.a. in the past 4 years.
More and more public dialysis centers in Europe are being privatized, many of them by specialized healthcare service providers such as B. Braun Avitum.
The number of patients with kidney failure is increasing by 5-7% per year. That is due to the rapid change in lifestyle and the increase of related illnesses. In Europe, more than 300,000 patients and over 1,500,000 renal patients worldwide have End-Stage Renal Disease (ESRD) and require medical support and treatment.